Although UBASH3B has clear tumor-suppressive functions, numerous studies have also identified it as an oncogenic driver, particularly by disrupting ubiquitin-mediated degradation of oncogenic proteins and enhancing pro-tumorigenic signaling pathways. This evidence concerns the gene UBASH3B and neoplasm.